Search Results for "Beacopp Hd16 Hodgkin"
Original Source: HD16 for Early Stage Hodgkin Lymphoma
This study is designed to test the non-inferiority of the experimental arm compared to the experimental arm in terms of Progression free survival (PFS).
Matching Channels
Hodgkin Lymphoma is a disorder caused by malignant proliferation of lymphocytes, which contain characteristic mirror-image nuclei (Reed-Sternburg cells). The resulting lymphadenopathy can be l...
Lymphoma is a cancer of the lymph nodes; classified as Hodgkin or non-Hodgkin lymphoma. Malignancy varies, and the prognosis can be from a few months to many years. Symptoms include enlarged lymph...
CD30, also known as TNFRSF8, is a cell membrane protein of the tumor necrosis factor receptor family and tumor marker. This receptor is expressed by activated, but not by resting, T and B cells. It...
The European Organization for Rare Diseases considers orphan diseases to be those that are rare (occur in 1 in 1500 to 1 in 2500 patients, according to US Rare Disease Act 2002 and European Commissi...
Myc is the protein encoded by the MYC gene that activates the cell cycle
Myc is the protein encoded by the MYC gene that activates the cell cycle. It promotes cell replication through genetic coding for p14, inhibiting MDM2 and preventing the degradation of the pro-apopt...
Matching News
[Seminar] Non-Hodgkin lymphoma
Lymphomas are solid tumours of the immune system. Hodgkin's lymphoma accounts for about 10% of all lymphomas, and the remaining 90% are referred to as non-Hodgkin lymphoma. Non-Hodgkin lymphomas have...
Arlen Specter released, has non-Hodgkin's lymphoma
Former Sen. Arlen Specter, who has already survived two bouts of Hodgkin's disease, is now battling non-Hodgkin's lymphoma, according to his son's law firm.A statement released Friday said Specter, 8...
Arlen Specter released, has non-Hodgkin's lymphoma
Former Sen. Arlen Specter, who has already survived two bouts of Hodgkin's disease, is now battling non-Hodgkin's lymphoma, according to his son's law firm.A statement released Friday said Specter, 8...
CT Overused in Monitoring Pediatric Hodgkin's Lymphoma
Computed tomography (CT) should not be used for the surveillance of pediatric Hodgkin's lymphoma after a year. Medscape Medical News
Hodgkin’s lymphoma drug to launch soon
Brentuximab vedotin is due to be launched next week (19 November 2012) for the treatment of relapsed or refractory Hodgkin’s lymphoma...
Diagnovus launches tumor tissue test for non-Hodgkin lymphoma
Diagnovus has launched Engauge, a genetic test for the evaluation of non-Hodgkin lymphoma tumors. -More-
OK to Skip Radiation in Some Children with Hodgkin Lymphoma
Children with favorable-risk Hodgkin lymphoma may be able to forgo radiation therapy without affecting their outcomes. Medscape Medical News
Immune Protein Levels Predict Hodgkin Disease Risk
The amount of an immunity-related protein in the blood of patients with newly diagnosed Hodgkin lymphoma reflected the extent...
Matching PubMed Articles
ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned.
BEACOPP, an intensified regimen consisting of bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone, has been advocated as the new standard of treatment for ad...
PURPOSE Eight cycles of BEACOPP(escalated) (escalated dose of bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone) followed by radiotherapy (RT) to initial b...
ABVD versus BEACOPP for Hodgkin's lymphoma.
